Table 2.
Procedural and periprocedural characteristics.
| n (all) | 253 (100%) |
|---|---|
| Periprocedural data | |
| Elective procedure, n = (%) | 225 (82.9) |
| Minimally invasive upper hemisternotomy approach, n = (%) | 59 (23.3) |
| Perfusion time (minutes), median (IQR) | 111 (89–154) |
| Aortic cross clamp time (minutes), median (IQR) | 79 (61–105.5) |
| ICU stay (days), median (IQR) | 2 (1–3) |
| Hospital stay (days), median (IQR) | 9 (7–13) |
| Cardiac procedure | |
| AV surgery, n = (%) | 235 (92.9) |
| MV surgery, n = (%) | 37 (14.6) |
| TV surgery, n = (%) | 15 (5.9) |
| CABG, n = (%) | 63 (24.9) |
| Prior cardiac surgery | |
| AV surgery, n = (%) | 17 (6.7) |
| Aortic surgery, n = (%) | 3 (1.2) |
| Ascending aortic surgery, n = (%) | 1 (0.4) |
| Cardiac and aortic reoperation | |
| AV surgery, n = (%) | 6 (2.4) |
| Aortic surgery, n = (%) | 3 (1.2) |
| Ascending aortic surgery, n = (%) | 0 |
Aortic surgery: two patients underwent previous surgical infrarenal aortic aneurysm replacement by dacron prothesis and one patient underwent prior Reduction Ascending Aortoplasty; AV, Aortic Valve; AVR, Aortic Valve Replacement; CABG, Coronary Aortic Bypass; ICU, Intensive Care Unit; IQR, Interquartile Range; MV, Mitral Valve; TV, Tricuspid Valve.